Dr. Reddy's Laboratories (RDY) Earnings Date, Estimates & Call Transcripts $73.98 -1.17 (-1.56%) (As of 10:55 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 1EstimatedActual EPS (Jul. 27) $1.00 Missed By -$0.10 Consensus EPS (Jul. 27) $1.10 Get Dr. Reddy's Laboratories Earnings AlertsEnter your email address below to receive the latest news and earnings results for RDY and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRDY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RDY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyBanking failure dead aheadIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Dr. Reddy's Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.71$0.71$0.71Q2 20241$0.88$0.88$0.88Q3 20241$0.87$0.87$0.87Q4 20241$0.86$0.86$0.86FY 20244$3.32$3.32$3.32Q1 20251$1.10$1.10$1.10Q2 20251$0.99$0.99$0.99Q3 20251$1.00$1.00$1.00Q4 20251$1.00$1.00$1.00FY 20254$4.09$4.09$4.09Q1 20261$1.01$1.01$1.01Q2 20261$1.00$1.00$1.00Q3 20261$1.01$1.01$1.01Q4 20261$1.04$1.04$1.04FY 20264$4.06$4.06$4.06Q1 20271$0.95$0.95$0.95Q2 20271$0.78$0.78$0.78RDY Earnings Date and InformationDr. Reddy's Laboratories last released its earnings results on July 27th, 2024. The reported $1.00 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.10 by $0.10. The business earned $919.80 million during the quarter, compared to analyst estimates of $861.68 million. Dr. Reddy's Laboratories has generated $4.03 earnings per share over the last year ($4.03 diluted earnings per share) and currently has a price-to-earnings ratio of 18.8. Earnings for Dr. Reddy's Laboratories are expected to grow by 0.49% in the coming year, from $4.11 to $4.13 per share. Dr. Reddy's Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off prior year's report dates.Read More Dr. Reddy's Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/1/2024(Estimated)------- 7/27/2024Q1 2025$1.10$1.00($0.10)$1.00$861.68 million$919.80 million5/7/2024Q4 2024$0.86$0.94+$0.08$0.94$825.20 million$850.00 million1/31/2024Q4 2023$0.88$0.99+$0.11$0.99$827.81 million$867.00 million 10/27/2023Q2 2024$0.88$1.07+$0.19$1.07$825.94 million$832.16 million7/26/2023Q1 2024$0.71$1.03+$0.32$1.03$790.67 million$820.20 million5/10/2023Q4 2023$0.57$0.70+$0.13$0.70$763.37 million$766.00 million Get the Latest News and Ratings for RDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. 1/25/2023Q3 2023$0.60$0.91+$0.31$0.91$769.25 million$818.00 million10/28/2022Q2 2023$0.59$0.82+$0.23$0.82$763.28 million$775.00 million7/28/2022Q1 2023$0.58$0.90+$0.32$0.90$767.00 million$660.00 million5/19/2022Q4 2022-$0.53+$0.53$0.99-$717.00 million1/28/2022Q3 2022-$0.57+$0.57$0.57-$715.00 million10/29/2021Q3 2021$0.56$0.80+$0.24$0.80-$777.00 million7/27/2021Q2 2021$0.55$0.46($0.09)$0.46$685.22 million$662.00 million5/13/2021Q1 2021$0.51$0.46($0.05)$0.46-$646.00 million 1/29/2021Q3 2021-$0.41+$0.41$0.80-$675.00 million10/28/2020Q3 2020$0.50$0.62+$0.12$0.62-$666.00 million 7/29/2020Q2 2020$0.42$0.46+$0.04$0.46-$585.00 million 5/20/2020Q1 2020$0.49$0.61+$0.12$0.61$552.28 million$588.00 million 1/27/2020Q3 2020-$0.40+$0.40$1.28-$614.00 million11/1/2019Q2 2020-$0.93+$0.93$0.93-$680.00 million Dr. Reddy's Laboratories Earnings - Frequently Asked Questions When is Dr. Reddy's Laboratories's earnings date? Dr. Reddy's Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off last year's report dates. Learn more on RDY's earnings history. Did Dr. Reddy's Laboratories beat their earnings estimates last quarter? In the previous quarter, Dr. Reddy's Laboratories (NYSE:RDY) missed the analysts' consensus estimate of $1.10 by $0.10 with a reported earnings per share (EPS) of $1.00. Learn more on analysts' earnings estimate vs. RDY's actual earnings. How much revenue does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded annual revenue of $288.51 billion. How much profit does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded net income of $668 million. RDY has generated $4.03 earnings per share over the last four quarters. What is Dr. Reddy's Laboratories's price-to-earnings ratio? Dr. Reddy's Laboratories (NYSE:RDY) has a trailing price-to-earnings ratio of 18.80 and a forward price-to-earnings ratio of 18.30. The price/earnings-to-growth ratio is 1.73. What is Dr. Reddy's Laboratories's EPS forecast for next year? Dr. Reddy's Laboratories's earnings are expected to grow from $4.11 per share to $4.13 per share in the next year, which is a 0.49% increase. ` More Earnings Resources from MarketBeat Related Companies Takeda Pharmaceutical Earnings Date BioNTech Earnings Date BeiGene Earnings Date Teva Pharmaceutical Industries Earnings Date Ginkgo Bioworks Earnings Date Moderna Earnings Date Genmab A/S Earnings Date Summit Therapeutics Earnings Date Viatris Earnings Date Vaxcyte Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying Opportunity This page (NYSE:RDY) was last updated on 10/30/2024 by MarketBeat.com Staff From Our PartnersMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredThis biotech's ONE drug could change medicine as we know itThis Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses...Smallcaps Daily | Sponsored2 Pro Traders… 4 Livestreams… 4 Live TradesThe Zero Day Loophole: The Secret of HUGE Overnight Profits from Government ReportsMonument Traders Alliance | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
